Cannabis Investing Kalytera Announces Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
Cannabis Investing Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD
Cannabis Investing Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group
Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone
High Grade surface silver results up to 920g/t Ag recorded ~300m to the north and ~150m to the south of Elizabeth Hill mineralisation
